Apogee Therapeutics, Inc.
APGE
42 insider filings · Latest: Sep 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | Mar 28 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $85.00 | $170.0K | 179,371(D) | View → |
| Mar 25, 2026 | Mar 25 8:24 PM | JANE HENDERSON | Proposed Sale | 6,000 | $73.00 | $438.0K | — | View → |
| Mar 11, 2026 | Mar 14 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $74.78 | $1.5M | 1,152,987(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $71.06 | $390.8K | 209,773(D) | View → |
| Mar 2, 2026 | Mar 5 1:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $70.22 | $140.4K | 181,371(D) | View → |
| Feb 11, 2026 | Feb 14 1:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $63.35 | $1.3M | 1,172,987(D) | View → |
| Feb 11, 2026 | Feb 11 3:42 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 60,000 | $64.00 | $3.8M | — | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $65.79 | $361.9K | 211,148(D) | View → |
| Feb 2, 2026 | Feb 5 1:01 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $65.81 | $131.6K | 183,371(D) | View → |
| Jan 22, 2026 | Jan 23 1:07 AM | Fairmount Funds Management LLCDirector | Sale | 1,750,000 | $76.30 | $133.5M | 298,647(I) | View → |
| Jan 22, 2026 | Jan 23 1:03 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 1,750,000 | $76.30 | $133.5M | — | View → |
| Jan 14, 2026 | Jan 17 1:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $81.11 | $1.6M | 1,192,987(D) | View → |
| Jan 7, 2026 | Jan 7 9:27 PM | CARL DAMBKOWSKI | Proposed Sale | 35,200 | $78.25 | $2.8M | — | View → |
| Jan 2, 2026 | Jan 2 9:31 PM | JANE HENDERSON | Proposed Sale | 12,000 | $75.48 | $905.8K | — | View → |
| Dec 19, 2025 | Dec 19 9:24 PM | JANE HENDERSON | Proposed Sale | 1,500 | $77.35 | $116.0K | — | View → |
| Dec 4, 2025 | Dec 4 9:43 PM | JANE HENDERSON | Proposed Sale | 1,500 | $74.55 | $111.8K | — | View → |
| Dec 4, 2025 | Dec 4 9:41 PM | CARL DAMBKOWSKI | Proposed Sale | 10,900 | $74.55 | $812.6K | — | View → |
| Nov 25, 2025 | Nov 25 9:28 PM | JANE HENDERSON | Proposed Sale | 1,500 | $67.85 | $101.8K | — | View → |
| Nov 14, 2025 | Nov 14 9:31 PM | JANE HENDERSON | Proposed Sale | 2,000 | $62.97 | $125.9K | — | View → |
| Nov 13, 2025 | Nov 13 3:33 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 100,000 | $66.98 | $6.7M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 20 8:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Option Exercise | 3,000 | $22.86 | 387,012(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 127,165(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 131,290(D) | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 135,415(D) | View → |
← Previous
Page 2 of 2